Dr. Reddy’s Signs License Deal for Once-Yearly Lenacapavir The Story:Dr. Reddy’s has signed a royalty-free, non-exclusive license agreement with Gilead Sciences for investigational once-yearly lenacap...
Key Highlights: Implications: Alkem’s launch of NeuCeno (cenobamate) introduces India’s first cenobamate-based anti‑seizure medication for adults with partial‑onset seizures, adding a high...
